These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1079 related articles for article (PubMed ID: 22969192)
1. Results of National Colorectal Cancer Screening Program in Croatia (2007-2011). Katičić M; Antoljak N; Kujundžić M; Stamenić V; Skoko Poljak D; Kramarić D; Stimac D; Strnad Pešikan M; Samija M; Ebling Z World J Gastroenterol; 2012 Aug; 18(32):4300-7. PubMed ID: 22969192 [TBL] [Abstract][Full Text] [Related]
2. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514 [TBL] [Abstract][Full Text] [Related]
3. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing. van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499 [TBL] [Abstract][Full Text] [Related]
4. Early Detection of Colorectal Cancer: a Multi-Center Pre-Clinical Case Cohort Study for Validation of a Combined DNA Stool Test. Dollinger MM; Behl S; Fleig WE Clin Lab; 2018 Oct; 64(10):1719-1730. PubMed ID: 30336540 [TBL] [Abstract][Full Text] [Related]
5. Contribution of the OC Sensor Vitellius C; Laly M; Banaszuk AS; Deherce I; Cornet N; Bertrais S; Saulnier P; Caroli-Bosc FX Eur J Epidemiol; 2019 Feb; 34(2):163-172. PubMed ID: 30536183 [TBL] [Abstract][Full Text] [Related]
6. Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: a pilot study. Gimeno-García AZ; Quintero E; Nicolás-Pérez D; Hernández-Guerra M; Parra-Blanco A; Jiménez-Sosa A Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1062-7. PubMed ID: 19307978 [TBL] [Abstract][Full Text] [Related]
7. [Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?]. Quintero E Gastroenterol Hepatol; 2009 Oct; 32(8):565-76. PubMed ID: 19577340 [TBL] [Abstract][Full Text] [Related]
8. [CONTRIBUTION OF FAMILY MEDICINE TO COLORECTAL CANCER PREVENTION AND EARLY DETECTION; FORTY-YEAR EXPERIENCE OF FAMILY MEDICINE DEPARTMENT, OSIJEK HEALTH CENTER]. Ebling Z Acta Med Croatica; 2015 Nov; 69(4):373-80. PubMed ID: 29084381 [TBL] [Abstract][Full Text] [Related]
9. Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study. Fraser CG; Matthew CM; Mowat NA; Wilson JA; Carey FA; Steele RJ Lancet Oncol; 2006 Feb; 7(2):127-31. PubMed ID: 16455476 [TBL] [Abstract][Full Text] [Related]
10. Healthcare costs, resource utilization, and productivity loss associated with colorectal cancer screening. Engel-Nitz NM; Miller-Wilson LA; Le L; Fisher DA Expert Rev Pharmacoecon Outcomes Res; 2023; 23(7):843-852. PubMed ID: 37462667 [TBL] [Abstract][Full Text] [Related]
11. Organized colorectal cancer screening in Serbia - the first round within 2013-2014. Banković Lazarević D; Krivokapić Z; Barišić G; Jovanović V; Ilić D; Veljković M Vojnosanit Pregl; 2016 Apr; 73(4):360-7. PubMed ID: 29309104 [TBL] [Abstract][Full Text] [Related]
12. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589 [TBL] [Abstract][Full Text] [Related]
13. Screening for colorectal cancer in Italy: 2005 survey. Zorzi M; Barca A; Falcini F; Grazzini G; Pizzuti R; Ravaioli A; Sassoli de Bianchi P; Senore C; Sigillito A; Vettorazzi M; Visioli C Epidemiol Prev; 2007; 31(2-3 Suppl 2):49-60. PubMed ID: 17824362 [TBL] [Abstract][Full Text] [Related]
14. Comparison of guaiac and immunological fecal occult blood tests in colorectal cancer screening: the patient perspective. Deutekom M; van Rossum LG; van Rijn AF; Laheij RJ; Fockens P; Bossuyt PM; Dekker E; Jansen JB Scand J Gastroenterol; 2010 Nov; 45(11):1345-9. PubMed ID: 20560814 [TBL] [Abstract][Full Text] [Related]
15. [Results of the Czech National Colorectal Cancer Screening Programme - colonoscopy examinations]. Suchánek S; Májek O; Zavoral M; Seifert B; Ngo O; Dušek L Klin Onkol; 2014; 27 Suppl 2():98-105. PubMed ID: 25494894 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the performance of guaiac-based and two immunochemical fecal occult blood tests for identifying advanced colorectal neoplasia in Taiwan. Ou CH; Kuo FC; Hsu WH; Lu CY; Yu FJ; Kuo CH; Wang JY; Wu MT; Shiea J; Wu DC; Hu HM J Dig Dis; 2013 Sep; 14(9):474-83. PubMed ID: 23701988 [TBL] [Abstract][Full Text] [Related]
17. Ontario's ColonCancerCheck: results from canada's first province-wide colorectal cancer screening program. Rabeneck L; Tinmouth JM; Paszat LF; Baxter NN; Marrett LD; Ruco A; Lewis N; Gao J Cancer Epidemiol Biomarkers Prev; 2014 Mar; 23(3):508-15. PubMed ID: 24443406 [TBL] [Abstract][Full Text] [Related]
18. Fecal Occult Blood Test Results of the National Colorectal Cancer Screening Program in South Korea (2006-2013). Rim JH; Youk T; Kang JG; Park BK; Gee HY; Kim JH; Yoo J Sci Rep; 2017 Jun; 7(1):2804. PubMed ID: 28584248 [TBL] [Abstract][Full Text] [Related]
19. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program. Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542 [TBL] [Abstract][Full Text] [Related]